Reducing Nephrotoxicity of Vancomycin: A Prospective Study of Continuous Versus Intermittent Infusion of Vancomycin

NCT01720940 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Infections Requiring Prolonged Duration (>10 Days) of Vancomycin

Interventions

DRUG: continuous vancomycin infusion
DRUG: intermittent vancomycin infusion

Sponsor

National University Hospital, Singapore

Collaborators

[object Object]